Swiss perspectives in 10 languages

Switzerland reviews third anti-viral Covid vaccine

vaccination
The race is on worldwide to provide the first Covid-19 vaccine Copyright 2020 The Associated Press. All Rights Reserved.

The Swiss therapeutics products agency Swissmedic has started a review of another anti-Covid 19 vaccine – this time from United States biotech firm Moderna - in the rolling submission procedure.

This is the third authorisation procedure submitted in Switzerland for a vaccine against the novel coronavirus.

“The rolling submission procedure for mRNA-1273 is based on the initially submitted data packages on the preclinical situation and quality, as well as on preliminary clinical data. In a rolling review, the data can be evaluated as soon as they become available. The companies can then submit the latest data continuously without having to wait for the conclusive results from all studies,” Swissmedic said on FridayExternal link.

Swissmedic can thus obtain an initial picture of the benefit-risk profile of the vaccine candidates before the authorisation studies are completed (Phase III studies). This accelerates the review process while at the same time “preserving the same level of careful checking of all requirements relating to safety, efficacy and quality”, it explained.

The agency is already reviewing authorisation applications for Covid-19 vaccines from the companies AstraZeneca and Pfizer/BioNTech.

Vaccine strategy

On Wednesday Swiss government announced that it had earmarked an additional CHF100 million ($111 million) to buy an anti-Covid vaccine.

Interior Minister Alain Berset said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year.

So far, Switzerland has assured reservations for about 13 million doses of prospective vaccines from AstraZeneca and Moderna and an international programme by the World Health OrganizationExternal link (WHO). It is also in negotiations with Pfizer/BioNTech about assuring delivery. Swissmedic has to examine and approve any product before it is distributed.

Health officials estimate about 60-70% of the population must be inoculated against the new coronavirus to get the pandemic under control.

Coronavirus infections in Switzerland rose by 6,739, the federal health authorities said on Friday. The death toll increased by 97.

More
Doctor administering a vaccine

More

Swiss stump up more cash to buy a Covid-19 vaccine

This content was published on Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year. So far, Switzerland has assured reservations for about 13 million doses of prospective…

Read more: Swiss stump up more cash to buy a Covid-19 vaccine

Popular Stories

Most Discussed

News

Gay activist Ernst Ostertag celebrates his 95th birthday

More

Swiss gay rights activist Ernst Ostertag turns 95

This content was published on Ernst Ostertag is a pioneer for the legal equality of homosexual people in Switzerland. In an interview with "SonntagsBlick" on the occasion of his 95th birthday, the Zurich native explains what bothers him about the Woke movement.

Read more: Swiss gay rights activist Ernst Ostertag turns 95
Swiss Post CEO Roberto Cirillo steps down at the end of March after six years

More

Swiss Post CEO to step down

This content was published on The boss of Swiss Post, Roberto Cirillo, is stepping down at the end of March after six years in the job, the company announced on Friday.

Read more: Swiss Post CEO to step down
UBS replaces CS logos on Paradeplatz

More

UBS takes over Credit Suisse’s former Zurich HQ

This content was published on The name and logo of the former Credit Suisse headquarters at Paradeplatz 8 in Zurich's financial centre were officially replaced by those of UBS on Friday.

Read more: UBS takes over Credit Suisse’s former Zurich HQ

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR